PRINCETON, N.J.--(BUSINESS WIRE)--PhytoMedical Technologies, Inc. (OTCBB: PYTO) (FWB: ET6), today announced the addition of Dr. Mark A. Bossie, a specialist in the identification, development, and licensing of new pharmaceuticals and therapeutics, to the Company’s Scientific Advisory Board.
